KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Bionano Genomics (BNGO) Return on Sales (2017 - 2025)

Bionano Genomics' Return on Sales history spans 7 years, with the latest figure at 1.15% for Q3 2025.

  • For Q3 2025, Return on Sales rose 613.0% year-over-year to 1.15%; the TTM value through Sep 2025 reached 1.34%, up 273.0%, while the annual FY2024 figure was 3.64%, 280.0% up from the prior year.
  • Return on Sales for Q3 2025 was 1.15% at Bionano Genomics, down from 1.02% in the prior quarter.
  • Across five years, Return on Sales topped out at 0.48% in Q1 2025 and bottomed at 12.08% in Q3 2023.
  • The 5-year median for Return on Sales is 4.41% (2022), against an average of 4.16%.
  • The largest annual shift saw Return on Sales crashed -768bps in 2023 before it skyrocketed 613bps in 2025.
  • A 5-year view of Return on Sales shows it stood at 3.64% in 2021, then decreased by -29bps to 4.71% in 2022, then grew by 13bps to 4.09% in 2023, then skyrocketed by 40bps to 2.47% in 2024, then soared by 53bps to 1.15% in 2025.
  • Per Business Quant, the three most recent readings for BNGO's Return on Sales are 1.15% (Q3 2025), 1.02% (Q2 2025), and 0.48% (Q1 2025).